PMS38 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN COMPARISON WITH ANAKINRA IN SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA) TREATMENT IN TURKEY

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1582
https://www.valueinhealthjournal.com/article/S1098-3015(19)33960-9/fulltext
Title : PMS38 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN COMPARISON WITH ANAKINRA IN SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA) TREATMENT IN TURKEY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33960-9&doi=10.1016/j.jval.2019.09.1582
First page :
Section Title :
Open access? : No
Section Order : 11369
Categories :
Tags :
Regions :
ViH Article Tags :